These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20078837)

  • 1. Metabolic syndrome: signs and symptoms running together.
    Brady TM; Parekh RS
    Pediatr Transplant; 2010 Feb; 14(1):6-9. PubMed ID: 20078837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in subjects with essential hypertension: relationships with subclinical cardiovascular and renal damage.
    Mulé G; Cottone S; Nardi E; Andronico G; Cerasola G
    Minerva Cardioangiol; 2006 Apr; 54(2):173-94. PubMed ID: 16778751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome after kidney transplantation.
    Bellinghieri G; Bernardi A; Piva M; Pati T; Stoppa F; Scaramuzzo P; Garizzo O; Santoro D; Savica V; Bucciante G
    J Ren Nutr; 2009 Jan; 19(1):105-10. PubMed ID: 19121783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical study of the risk factors of insulin resistance and metabolic syndrome after kidney transplantation.
    Sui W; Zou H; Zou G; Yan Q; Chen H; Che W; Xie S
    Transpl Immunol; 2008 Nov; 20(1-2):95-8. PubMed ID: 18703143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic syndrome and atherosclerotic events in renal transplant recipients.
    Courivaud C; Kazory A; Simula-Faivre D; Chalopin JM; Ducloux D
    Transplantation; 2007 Jun; 83(12):1577-81. PubMed ID: 17589340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Risk factors and pathogenetic mechanisms of left ventricular hypertrophy in progressive chronic kidney disease and after transplantation of the kidney].
    Tomilina NA; Storozhakov GI; Gendlin GE; Badaeva SV; Zhidkova DA; Kim IG; Borisovskaia SV; Loss KE; Fedorova ND
    Ter Arkh; 2007; 79(6):34-40. PubMed ID: 17684964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic syndrome after kidney transplantation.
    Faenza A; Fuga G; Nardo B; Donati G; Cianciolo G; Scolari MP; Stefoni S
    Transplant Proc; 2007; 39(6):1843-6. PubMed ID: 17692629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unexpectedly high prevalence of pretransplant abnormal glucose tolerance in pediatric kidney transplant recipients.
    Shishido S; Sato H; Asanuma H; Shindo M; Hataya H; Ishikura K; Hamasaki Y; Goto M; Ikeda M; Honda M
    Pediatr Transplant; 2006 Feb; 10(1):67-73. PubMed ID: 16499590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is related to long-term graft function in renal transplant recipients.
    Ozdemir FN; Karakan S; Akgul A; Haberal M
    Transplant Proc; 2009 Sep; 41(7):2808-10. PubMed ID: 19765441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic syndrome is associated with severe coronary artery disease and poor cardiac outcome in end-stage renal disease patients with acute coronary syndrome.
    Chen HH; Wu CJ; Chen YC; Tsai CS; Lin FJ; Yeh HI
    Coron Artery Dis; 2006 Nov; 17(7):593-6. PubMed ID: 17047442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of metabolic syndrome and obesity in renal transplanted Mexican children.
    Ramirez-Cortes G; Fuentes-Velasco Y; García-Roca P; Guadarrama O; López M; Valverde-Rosas S; Velásquez-Jones L; Romero B; Toussaint G; Medeiros M
    Pediatr Transplant; 2009 Aug; 13(5):579-84. PubMed ID: 18992053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of living donor kidney transplantation on markers of cardiovascular risk in chronic kidney disease patients.
    Bignelli AT; Barberato SH; Aveles P; Abensur H; Pecoits-Filho R
    Blood Purif; 2007; 25(3):233-41. PubMed ID: 17377377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of risk factors for cardiovascular disease in Brazilian renal transplant recipients.
    Souza FC; Silva MI; Motta EM; Guimarães SS; Souza E; Torres MR
    Transplant Proc; 2007 Mar; 39(2):446-8. PubMed ID: 17362755
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cardioprotection: an essential component for predialysis chronic renal failure treatment].
    Jungers P; Qualim Z; Nguyen-Khoa T; Massy Z; London G
    Nephrologie; 2003; 24(2):79-88. PubMed ID: 12723513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal manifestations in the metabolic syndrome.
    Locatelli F; Pozzoni P; Del Vecchio L
    J Am Soc Nephrol; 2006 Apr; 17(4 Suppl 2):S81-5. PubMed ID: 16565254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic syndrome determinants in an urban population from Brazil: social class and gender-specific interaction.
    Marquezine GF; Oliveira CM; Pereira AC; Krieger JE; Mill JG
    Int J Cardiol; 2008 Sep; 129(2):259-65. PubMed ID: 18036678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Left ventricular hypertrophy in chronic kidney disease].
    Paoletti E; Cannella G
    G Ital Nefrol; 2006; 23(6):560-8. PubMed ID: 17173262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology of cardiovascular disease in chronic renal disease.
    Foley RN; Parfrey PS; Sarnak MJ
    J Am Soc Nephrol; 1998 Dec; 9(12 Suppl):S16-23. PubMed ID: 11443763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
    Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
    Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.